FET proteins are relevant in several different cancers [72] and point mutations in either FUS or TAF15, some of which affect their nuclear–cytoplasmic shuttling, can cause neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal lobar dementia (FTD) [73, 74]. This evidence concerns the gene FUS and cancer.